八木 洋

Medicine & Life Sciences

1. Liver Transplantation 100%
2. Liver 88%
3. Living Donors 77%
4. Pancreatic Neoplasms 48%
5. Swine 39%
6. Mesenchymal Stem Cells 38%
7. Hepatocellular Carcinoma 37%
8. Neoplasms 35%
9. Hepatectomy 33%
10. Acute Liver Failure 28%
11. Adenocarcinoma 28%
12. Transplantation 27%
13. Transplants 26%
14. Pancreatectomy 26%
15. Neoplasm Metastasis 24%
16. Hepatocytes 24%
17. Pancreatic Fistula 19%
18. Regenerative Medicine 19%
19. Pancreaticoduodenectomy 18%
20. Pancreas 18%
21. Therapeutics 18%
22. Tissue Donors 18%
23. Gallbladder 18%
24. Pancreatic Ducts 17%
25. Survival 17%
26. HMGB1 Protein 17%
27. Liver Failure 16%
28. Carcinoma 16%
29. Tomography 15%
30. Stem Cells 15%
31. Portal Vein 14%
32. High Mobility Group Proteins 14%
33. Bioengineering 14%
34. Liver Regeneration 14%
35. Perfusion 13%
36. Organ Transplantation 13%
37. Cryosurgery 12%
38. Recurrence 12%
39. Neuroendocrine Tumors 12%
40. Induced Pluripotent Stem Cells 12%
41. olanexidine 11%
42. Lymph Nodes 11%
43. Pheochromocytoma 11%
44. Biliary Tract 11%
45. Wounds and Injuries 11%
46. Cell Transplantation 10%
47. Biomarkers 10%
48. Animals 10%
49. retrorsine 10%
50. Heterografts 10%